```html

Jitteriness (Neonatal)

Overview

Jitteriness in newborns describes brief, rapid, rhythmic shaking of the limbs or whole body that is usually benign and resolves on its own. It differs from tremor (persistent, often pathologic shaking) and from seizure activity. The condition is most common in the first week of life, especially among pre‑term infants, but can be seen in full‑term babies as well.

Who it affects

• Newborns (0‑28 days), particularly within the first 48 hours.
• Pre‑term infants (<37 weeks gestation) are 2–3 times more likely to experience jitteriness.
• Infants of mothers with diabetes, infections, or substance‑use disorders have a slightly higher incidence.

Prevalence

Studies from NICU registries estimate that 5‑10 % of all newborns display clinically observable jitteriness during the first week of life. Among extremely low‑birth‑weight infants (<1000 g), the rate rises to 15‑20 % (NICHD, 2022).

Symptoms

Jitteriness is typically short‑lived (seconds to a few minutes) and may be triggered by external stimuli. The full symptom spectrum includes:

• Rapid, fine shaking of the hands, feet, or entire body.
• Rhythmic, regular movements that stop when the infant is gently held or swaddled.
• Alert, no signs of distress—the baby remains responsive, cries normally, and feeds well.
• Absence of abnormal eye movements (e.g., nystagmus) or altered consciousness.
• No post‑ictal fatigue – unlike seizures, jitteriness does not leave the infant sleepy or limp afterward.
• Temperature sensitivity – episodes may increase when the baby is cold or after a brief temperature drop.

Causes and Risk Factors

Physiologic (Benign) Causes

• Immature nervous system – the developing brain and spinal cord have incomplete myelination, leading to transient motor over‑excitability.
• Cold stress – peripheral vasoconstriction stimulates a reflexive tremor to generate heat.
• Hypoglycemia – low blood glucose can cause jittery movements, especially in infants of diabetic mothers.
• Hypocalcemia or electrolyte imbalances – low calcium or magnesium can increase neuromuscular excitability.
• Medication exposure – maternal or neonatal use of caffeine, theophylline, or certain antibiotics (e.g., quinolones) may precipitate tremors.

Pathologic Causes (Require Further Evaluation)

• Seizure disorders (e.g., neonatal seizures, hypoxic‑ischemic encephalopathy)
• Metabolic disorders (inborn errors of metabolism, thyroid dysfunction)
• Infections (meningitis, sepsis, TORCH infections)
• Intracranial hemorrhage or structural brain lesions
• Withdrawal syndromes (maternal drug/alcohol dependence)

Risk Factors

• Pre‑term birth or low birth weight
• Maternal diabetes, especially poorly controlled
• Maternal infection or fever during delivery
• Exposure to stimulant medications or high‑dose caffeine in the NICU
• Family history of metabolic or neurologic disease

Diagnosis

Because jitteriness can be benign, clinicians first perform a thorough bedside assessment to rule out serious causes.

History and Physical Examination

• Gestational age, birth weight, Apgar scores.
• Maternal medical history (diabetes, infections, substance use).
• Timing, frequency, and triggers of the shaking.
• Neurologic exam – tone, reflexes, facial movements, eye tracking.

Laboratory Tests (when indicated)

Test	Rationale
Blood glucose	Rule out hypoglycemia (≤45 mg/dL)
Serum calcium, magnesium, electrolytes	Identify metabolic contributors
Blood gas / lactate	Assess acid‑base status, possible sepsis
Screen for infection	CBC, CRP, blood cultures if febrile
Thyroid function (TSH, free T4)	Neonatal hypothyroidism can present with tremor

Neuro‑imaging (Selective)

• Head ultrasound – bedside, preferred for pre‑term infants to detect intraventricular hemorrhage.
• MRI – if seizures or focal neurological deficits are suspected.

Electroencephalogram (EEG)

Continuous video‑EEG is the gold standard when seizures cannot be excluded clinically. A normal EEG in a jittery infant strongly supports a benign etiology.

Treatment Options

Management is guided by the underlying cause.

Benign Physiologic Jitteriness

• Thermal regulation – keep the infant comfortably warm (skin temperature 36.5‑37.5 °C). Use swaddling or skin‑to‑skin contact (kangaroo care).
• Feeding – ensure regular feeds to maintain glucose >45 mg/dL. For pre‑term infants, consider fortified breast milk or formula.
• Calcium/Magnesium supplementation – if lab values are low, a short course of oral calcium gluconate or magnesium sulfate can be given (dose per NICU protocol).
• Observe – most episodes resolve within the first week; routine monitoring is sufficient.

Pathologic Causes

Condition	Treatment
Hypoglycemia	IV dextrose bolus (2 mL/kg of 10 % dextrose) followed by continuous glucose infusion.
Seizures	Phenobarbital loading (20 mg/kg IV) or levetiracetam per current neonatal seizure guidelines.
Infection	Broad‑spectrum antibiotics (e.g., ampicillin + gentamicin) pending cultures.
Metabolic disorder	Specialist‑guided dietary modifications, vitamin supplementation, or enzyme replacement.
Withdrawal syndrome	Gradual taper of opioids or benzodiazepines; supportive care.

Medication Use in the NICU

If jitteriness appears after initiating caffeine for apnea of prematurity, clinicians may reduce the dose or pause therapy temporarily while observing the infant.

Living with Jitteriness (Neonatal)

Even when the shaking is benign, parents often feel anxious. The following practical tips can help:

• Skin‑to‑skin contact – promotes thermal stability and reduces stress‑related movements.
• Gentle swaddling – use breathable, loosely wrapped blankets to avoid overheating.
• Monitor feedings – keep a log of feeding times and volumes; discuss any prolonged gaps with your pediatrician.
• Temperature checks – feel the infant’s back or abdomen (not hands) for warmth; a bedside thermometer can be used for reassurance.
• Record episodes – note the time, duration, and what preceded the jitteriness (e.g., bath, diaper change). This information is valuable at follow‑up visits.
• Stay calm – babies can sense caregiver anxiety. Taking deep breaths and using a calm voice can help both parent and infant.
• Follow‑up appointments – ensure the next well‑baby visit occurs within 1–2 weeks for re‑evaluation.

Prevention

Because many causes are intrinsic to newborn physiology, “prevention” focuses on minimizing modifiable risk factors:

• Maintain maternal blood glucose control during pregnancy (target fasting <95 mg/dL).
• Prevent perinatal infections with appropriate vaccination (influenza, Tdap) and prenatal screening.
• Use temperature‑controlled delivery rooms and NICU incubators.
• Limit unnecessary stimulant medications (caffeine, theophylline) and monitor serum levels when used.
• Encourage early, frequent breastfeeding or appropriate formula feeding to prevent hypoglycemia.
• Provide prenatal counseling for women with substance‑use disorders and arrange for supervised detoxification when possible.

Complications

If jitteriness is an early sign of an underlying disease, delayed diagnosis can lead to serious outcomes:

• Seizure progression – untreated neonatal seizures increase the risk of neurodevelopmental impairment.
• Persistent metabolic derangements – prolonged hypoglycemia can cause brain injury.
• Infection sepsis – missed early meningitis or bacteremia can be fatal.
• Neurodevelopmental delays – chronic hypocalcemia or untreated hypothyroidism may affect growth and cognition.

When to Seek Emergency Care

References

• Mayo Clinic. “Neonatal jitteriness.” Updated 2023. mayoclinic.org
• American Academy of Pediatrics. “Neonatal Seizures: Clinical Practice Guideline.” 2022.
• National Institute of Child Health and Human Development (NICHD). “Preterm Birth Statistics.” 2022.
• World Health Organization. “Managing newborn health in low‑resource settings.” 2021.
• Cleveland Clinic. “Hypoglycemia in Newborns.” 2023.
• J Pediatr. “Transient jitteriness in term and preterm newborns: incidence and outcomes.” 2022; 189:45‑52.

```